Previous 10 | Next 10 |
Strengthening Board of Directors with Expertise in Innovative Product Launches NEW YORK, May 26, 2021 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiat...
TMDX presented data to the FDA advisory panel committee on their OCS Heart preservation device for extended criteria hearts for cardiac transplantation. The advisory panel voted in favor of all three categories: 1) safety, 2) efficacy, and 3) risk/benefit. FDA will most likely nar...
Transmedics Group, Inc. (TMDX) Q1 2021 Earnings Conference Call May 04, 2021, 16:30 ET Company Participants Lynn Lewis - Gilmartin Group Waleed Hassanein - Founder, MD, CEO, President & Director Stephen Gordon - CFO, Treasurer & Secretary Conference Call Participants Cecilia Furlong -...
TransMedics Group (TMDX): Q1 GAAP EPS of -$0.29 beats by $0.01.Revenue of $7.1M (-5.7% Y/Y) in-line.Press Release For further details see: TransMedics Group EPS beats by $0.01, revenue in-line
TransMedics Reports First Quarter 2021 Financial Results PR Newswire ANDOVER, Mass. , May 4, 2021 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with ...
It may surprise you to learn that many donated organs never get used. Less than a third of donated hearts and less than a quarter of donated lungs end up making their way to a recipient. But a company called TransMedics (NASDAQ: TMDX) hopes to change that, looking to disrupt the...
TransMedics to Report First Quarter 2021 Financial Results on May 4, 2021 PR Newswire ANDOVER, Mass. , April 20, 2021 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therap...
TMDX is a medical device company with a revenue generating stream and upcoming catalysts. Its organ care system is a novel concept that works better than current standards. They recently got a positive advisory committee vote. For further details see: TransMedics: Organ ...
Today pre-market analyst action includes downgrades on Fibrogen and ACADIA due to recent FDA decisions on companies’ new drug applications.Fibrogen slips as analysts weigh in on safety updateFibrogen (FGEN) shares plunged in the post-market yesterday in reaction to clarification m...
SOS (SOS) +36%.Titan Medical (TMDI) +25%.CBAK Energy Technology (CBAT) +21%.Altimeter Growth (AGCUU) +18%.CA Healthcare Acquisition (CAHCU) +16%.TransMedics (TMDX) +16%. as FDA Advisory Panel has issued a favorable vote in support of approval of the OCS Heart System.Altimeter Growth (AGC...
News, Short Squeeze, Breakout and More Instantly...
TransMedics Group Inc. Company Name:
TMDX Stock Symbol:
NYSE Market:
TransMedics Group Inc. Website:
TransMedics to Report Second Quarter 2024 Financial Results on July 31, 2024 PR Newswire ANDOVER, Mass. , July 17, 2024 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant...
2024-07-04 23:50:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Shares of TransMedics Group, Inc. (NASDAQ: TMDX) traded at a new 52-week high today and are currently trading at $139.5. So far today, approximately 249.23k shares have been exchanged, as compared to an average 30-day volume of 655.52k shares. TransMedics Group, Inc., a commercial-stage medic...